维普中文期刊产品整合服务
46篇 您的检索式:作者名="YEAP B Y"
    题名 作者 年代 出处 被引量
1Effect ofcrizotinib on overall survival in patients with advancednon-small-cell lung cancer harbouring ALK generearrangement:a retrospective analysis 显示文摘Shaw A T Yeap B Y Solomon B J 2011Lancet Oncol2011,12,11:1
2Clinical features and outcome of patiens with non-small-cell lung cancer who harbor EML4-ALK显示文摘Shaw A T Yeap B Y Mino-Kenudson M Digumarthy S R Costa D B Heist R S 2009J Clin Oncol2009,27,:1
3Megestrol and tamoxifenin patients with advanced endometrial cancer : an Eastern Cooperative Oncology Group Study (E4882) 显示文摘 Yeap B Y Weincr L M 2001Am J Clin Oncol2001,24,1:1
4Clinical fea- tures and outcome of patients with non-smal显示文摘Shaw A T Yeap B Y Mino-Kenudson M 2009J Clin Oncol2009,27,26:1
5Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma 显示文摘SHOLL L M BARLETTA J A YEAP B Y 2010Am J Surg Pathol2010,34,1:1
6Phase Ⅱ clinical trail of chemotherapy-naive patients ≥70 years of age treated with erlotinib for advanced nonsmall-cell lung cancer显示文摘Jackman D M Yeap B Y Lindeman N I 0,,08:1
7Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli 2011Lancet Oncology2011,,11:1
8Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib 显示文摘Jackman D M Yeap B Y Sequist L V 2006Clin Cancer Res2006,12,13:1
9Erlotinib at a dose of 25 mg daily for non small cell lung cancers with EGFR mutations显示文摘Yeo W L Riely G J Yeap B Y 2010J ThoracOncol2010,5,7:1
10Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib显示文摘Jackman D M Yeap B Y Sequist L V 2006Clin Cancer Res2006,12,13:1
11Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli 2011Lancet Oncology2011,,11:1
12Sox2 protein ex- pression is an independent poor prognostic indicator in stage I lung adenocarcinoma 显示文摘Sholl L M Barletta J A Yeap B Y 2010Am J Surg Pathol2010,34,8:1
13Clinical features and outcome of patients with non - small - cell lung cancer who harbor EML4 -ALK显示文摘Shaw A T Yeap B Y Mino - Kenudson M 2009J Clin Oncol2009,27,26:1
14Clinical fea- tures and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK 显示文摘Shaw A T Yeap B Y Mino-Kenudson M 2009J Clin Oncol2009,27,26:1
15Phase II clinical trail of chemotherapy-naive patients ≥ 70 years of age treated with erlotinib for advanced non-small-cell lung cancer显示文摘Jackman D M Yeap B Y Lindeman N I 2007J Clin Oncol2007,25,:1
16Clinical fea- tures and outcome of patients with non-small-cell lung cancer who harbor EMIA-ALK显示文摘SHAW A T YEAP B Y MINO-KENUDSON M 2009J Clin Orwol2009,27,26:1
17Impact of crizotinib on survival in patients with advanced,ALK-positive NSCLC compared with historical controls显示文摘Shaw A T Yeap B Y Solomon B J 0,,:1
18Clinical fea- tures and outcome of patients with non-small-celllung cancer who harbor EML4-ALK显示文摘Shaw A T Yeap B Y Mino-Kenudson M 2009J Clin Oncol2009,27,26:1
19Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis显示文摘Alice T Shaw Beow Y Yeap Benjamin J Solomon Gregory J Riely Justin Gainor Jeffrey A Engelman Geoffrey I Shapiro Daniel B Costa Sai-Hong I Ou Mohit Butaney Ravi Salgia Robert G Maki Marileila Varella-Garcia Robert C Doebele Yung-Jue Bang Kimary Kulig Pauli 2011Lancet Oncology2011,,11:1
20Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK显示文摘SHAW A T YEAP B Y MINO-KENUDSON M 2009J Clin Oncol2009,27,26:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费